A Prospective Time and Motion Analysis Comparing Intravenous (IV) Vesus Subcutaneous (SC) Bortezomib in Patients with Multiple Myeloma (MM)

Nov 1, 2013, 00:00 AM
10.1016/j.jval.2013.08.597
https://www.valueinhealthjournal.com/article/S1098-3015(13)02502-3/fulltext
Section Title : Disease-Specific Studies
Section Order : 576
First Page : A427
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)02502-3&doi=10.1016/j.jval.2013.08.597
HEOR Topics :
Tags :
Regions :